Lobular Breast Cancer Alliance
As the only organization in the US dedicated to Invasive Lobular Breast Cancer (ILC), LBCA’s mission is to make all who are touched by ILC aware of its unique characteristics and the critical need for more ILC research; to be the go-to source for information on ILC studies, clinical trials and educational tools; to foster partnerships among patients, scientists, clinicians, and breast cancer organizations to increase dialogue about ILC and research advocacy; and to fund vital ILC research. Visit us at lobularbreastcancer.org
Recognizing and Redefining the Unique Path of Invasive Lobular Carcinoma by Dr. Jason Mouabbi
Shining a Spotlight on Lobular Breast Cancer: Global Lobular Breast Cancer Awareness Day - Oct. 15th
An Update from the UK: Interview with Lobular Breast Cancer UK’s Claire Turner
Lobular Research Chat with Dr. Julia Foldi
LBCA SAB Member Dr. Rita Mukhtar Discusses New ILC Research
LBCA Welcomes Dr. Anita Mamtani to the Scientific Advisory Board
Welcome to Jo Lynn Collins, new Metastatic ILC Patient Advocate Representative on the PAAB
Lobular Breast Cancer Chat with Dr. Randy Yeh, SNMMI/LBCA ILC Imaging Research Fellow
New Lobular Breast Cancer Research Program at Dana-Farber Cancer Institute
New Local Advocacy Team Launched in Cascadia
ILC Research Grant awardee Dr. Manisha Bahl Shares Her ILC Imaging Research Study Plan
Advocate Chat: First Recipient of Deborah Mueller Foundation Lobular Breast Cancer Research Grant
New Lobular Breast Cancer Program at Memorial Sloan Kettering: Interview with the Co-Directors
Global Lobular Breast Cancer Awareness Day - TMX Market Open in Toronto, Canada on October 15th
LBCA Global Lobular Breast Cancer Awareness Day - Shining a Spotlight on Lobular Breast Cancer
Hear from LBCA's New Grantees on their Winning ILC Studies
Interview with LBCA’s Newest Scientific Advisory Board (SAB) member, Dr. Rimawi
Hear from Dr. Marina Sharifi, recipient of the SNMMI - LBCA ILC Imaging Research Fellowship
Why Clinical Trial Participation is Important to Advance Breast Cancer Treatment
LBCA Lobular Breast Cancer Chat: Biomarkers as Tools in ILC
LBCA Announces 2nd Local Advocacy Team (LAT) - Meet LAT DMV (D.C, Maryland & Virginia)
Honoring Dr. Deborah Mueller - A Tribute Video
LBCA Interviews new Scientific Advisory Board Member Dr. Rebecca Shatsky
LBCA Announces First Local Advocacy Team
ILC Symposium 2023: Research Poster Interview with Baylee Porter, PhD
Highlights of 2023 International ILC Symposium
ILC Symposium 2023: Research Poster Interview with Simran Sandhu
LBCA Poster: Individuals with Invasive Lobular Carcinoma Raise Their Voices About ILC and Surgery
What's New in Screening and Treatment for Lobular Breast Cancer